Click the star to add/remove an item to/from your individual schedule.
You need to be logged in to avail of this functionality.

P349


Health knowledge in society: biomedical expertise, technologies, inclusion and inequality 
Convenors:
Renan da Silva (ETH Zurich)
Janaina Pamplona da Costa (UNICAMP)
Larry Au (The City College of New York, CUNY)
Andre Campos
Send message to Convenors
Format:
Traditional Open Panel

Short Abstract:

The implications of biomedical expertise and technologies for inequality have gained relevance as subject of Science and Technology Studies. This EASST/4S 2024 Open Panel aims to serve as a space of dialogue for those interested in that relationship in different cultural and political settings.

Long Abstract:

Recent developments in biomedical expertise and healthcare technologies raises questions regarding development, dependence, and inequality in contemporary societies. This EASST/4S 2024 Meeting Open Panel examines the relationship between different regimes of expert knowledge production in biomedicine and healthcare and social inequalities. STS researchers shed light on how scientists and policymakers have made efforts to include “the public” and affected communities in the making and co-production of biomedical expertise. However, critical questions remain on whether the democratic governance of expert knowledge is truly possible, and whether attempts to diversify science will have a lasting effect on creating more inclusive and trustworthy forms of science. This Open Panel aims to stimulate dialogue among researchers interested in the sociological inquiry of this relationship between expertise and inequality in different contexts and societies. We are particularly interested in work that takes place in global and transnational contexts, and in particular research conducted in the Global South. Questions to be pursued in this panel include, but are not limited to: How does expert knowledge and technology development in biomedicine and healthcare impact inequality in high-income and low- and middle-income societies differently? What is the role of democracy and civil society in driving biomedical innovation? How are emerging technologies (e.g., Genomics, Bioengineering, Computational Biology, Artificial Intelligence) changing the global infrastructure of biomedical expertise? How are emerging technologies reconfiguring expertise networks in healthcare, and what are their implications for inequality?

Accepted papers: